Most problems occurred in the mouth such as numbness (24%), product abnormal taste (12%), tingling (7%), and tongue discomfort (7%)
Human trials are needed to confirm its safety and effectiveness before widespread clinical use
Nutritional deficiency is caused by a lack of the vitamin in the diet, whereas acquired deficiency occurs when the intestinal absorption of the vitamin is interfered with by diseases and conditions such as pernicious anemia (an autoimmune disorder affecting intrinsic factor protein produced by gastric parietal cells), chronic atrophic gastritis, Crohn's and celiac diseases, gastric bypass surgery, and medications such as metformin, gastric acid secretion blockers (i.e., proton-pump inhibitors and H2-receptor antagonists), and others (2, 3)
Supplied in capsule format for controlled laboratory workflows, 5-Amino-1MQ supports reproducible experimental design while remaining strictly designated for research use only
These studies demonstrate that the product mitigates the pathological progression of NAFLD by regulating adipose and hepatic metabolism, providing a valuable tool for understanding NAFLD pathogenesis and new strategies for intervention
